ClinicalTrials.Veeva

Menu

Impact of New Standards for Tobacco Products Among Dual E-Cigarette/Combusted Cigarette Users - Project 2

Duke University logo

Duke University

Status

Completed

Conditions

Smoking, Cigarette
Nicotine Dependence
E-Cig Use
Smoking

Treatments

Other: normal nicotine content cigarettes
Other: very low nicotine content cigarettes
Other: Study e-cigarette

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05473585
Pro00105539
5R01DA048454 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of the study is to evaluate how limiting the nicotine content in regular cigarettes affects choices for regular cigarette and e-cigarette products. Eligible participants will be of legal age to purchase tobacco products and regularly use both e-cigarettes and regular cigarettes.

Full description

Participants in this study will undergo an in-person screening session where the study will be explained in detail and participants will answer questions and provide a breath sample. During the screening session, participants will also be asked to complete surveys. Eligible participants will then complete the training procedures during which they will select an e-cigarette device to use for future preference sessions. During the 4 preference sessions, participants will sample puffs from an e-cigarette and regular cigarette and answer questions about their experience with each. They will also complete a task during which they can choose to earn puffs from the e-cigarette or regular cigarette, or choose to not take any puffs. The 4 sessions will be the same except that a different combination of e-cigarette and regular cigarette is used at each session.

Enrollment

7 patients

Sex

All

Ages

21+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Legal age to purchase tobacco products;
  2. Regular user of EC and CC;
  3. Owns the e-cigarette device used most often;
  4. Agrees to abstain from using all tobacco products for 12 hours prior to each experimental session;
  5. Self-reporting tobacco flavored e-liquid is preferred or usual flavor e-liquid

Exclusion criteria

  1. Unstable medical conditions as determined by the licensed medical professional;

  2. Unstable psychiatric conditions as determined by the licensed medical professional or PI;

  3. Currently pregnant, breastfeeding, trying to become pregnant or unwilling to agree to use adequate protection to avoid pregnancy;

  4. Serious quit attempt of either or both products in the past 3 months resulting in >30 days of abstinence;

  5. Currently using nicotine replacement therapy or other pharmacotherapies as cessation aide;

  6. Plans to quit use of either EC or CC, or all tobacco products in the next 45 days;

  7. Self-reporting nicotine-free, CBD, or THC liquid is preferred or usual e-liquid;

  8. Vital signs outside of the following range (participants failing for vital signs will be allowed to re-screen once):

    1. Systolic blood pressure (BP) greater than or equal to 160 mm/hg
    2. Diastolic BP greater than or equal to 100 mm/hg
    3. Heart rate greater than or equal to 115 bpm;
  9. Allergy to propylene glycol or vegetable glycerin;

  10. Previous adverse reaction when using vaping device or e-liquid;

  11. Current or recent alcohol or drug abuse problems;

  12. Previous use of SPECTRUM or other reduced nicotine content cigarettes in past 3 months;

  13. Literate and able to independently complete and comprehend the consent form and other written study materials and measures.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

7 participants in 4 patient groups

Study EC + UB CC
Active Comparator group
Description:
Participants will make choices between the study e-cigarette (EC) device with tobacco flavor and their usual brand (UB) combusted cigarette (CC)
Treatment:
Other: Study e-cigarette
Study EC + NNC CC
Active Comparator group
Description:
Participants will make choices between the study EC device with tobacco flavor and the normal nicotine content (NNC) investigational CC
Treatment:
Other: normal nicotine content cigarettes
Other: Study e-cigarette
Study EC + VLNC CC
Experimental group
Description:
Participants will make choices between the study EC device with tobacco flavor and the very low nicotine content (VLNC) investigational CC
Treatment:
Other: very low nicotine content cigarettes
Other: Study e-cigarette
Own EC + UB CC
No Intervention group
Description:
Participants will make choices between their own EC device with their own tobacco flavor and their UB CC

Trial contacts and locations

1

Loading...

Central trial contact

Rachel Kozink; Alicia Holloway

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems